# Dose Escalation of Dexamethasone to Increase Duration of Transversus Abdominal Plane Block Following Cesarean Section

> **NCT03098420** · PHASE2,PHASE3 · TERMINATED · sponsor: **University of Alabama at Birmingham** · enrollment: 29 (actual)

## Conditions studied

- Post Surgical Pain

## Interventions

- **DRUG:** 2mg Dexamethasone
- **DRUG:** 4mg Dexamethasone
- **DRUG:** Ropivacaine (TAP blocks)
- **DRUG:** Morphine
- **DRUG:** Bupivacaine Hydrochloride
- **DRUG:** Normal saline 1ml
- **DRUG:** Normal saline 0.5ml

## Key facts

- **NCT ID:** NCT03098420
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-07
- **Primary completion:** 2021-05-20
- **Final completion:** 2021-05-20
- **Target enrollment:** 29 (ACTUAL)
- **Why stopped:** Low enrollment; recruitment challenges due to competing studies in women and infant center
- **Last updated:** 2021-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03098420

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03098420, "Dose Escalation of Dexamethasone to Increase Duration of Transversus Abdominal Plane Block Following Cesarean Section". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03098420. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*